SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-033345
Filing Date
2020-02-12
Accepted
2020-02-12 16:49:55
Documents
4
Period of Report
2020-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d877215d8k.htm 8-K 21416
2 EX-1.1 d877215dex11.htm EX-1.1 184125
3 EX-5.1 d877215dex51.htm EX-5.1 7605
4 GRAPHIC g877215g0212103015364.jpg GRAPHIC 2403
  Complete submission text file 0001193125-20-033345.txt   217873
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 20604932
SIC: 2836 Biological Products, (No Diagnostic Substances)